Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and...
Read More
Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and...
Read More
A Phase II Study of the Efficacy and Safety of Axitinib (Axi) Given on an Individualized Schedule...
Read More
A phase I, open label, dose escalation and cohort expansion study to evaluate the safety and...
Read More
A Phase 3 Trial to Compare Efficacy and Safety of Lenvatinib in Combination With Everolimus or...
Read More